(Chapter Eight)
Ling Ruonan, of course, knew the scale and market value of Lingyun Pharmaceutical Group under the name of Lingyun Group that Ouyang Feifei was referring to.
The market value of Lingyun Pharmaceutical was at least around one hundred billion yuan, and the Ling family controlled fifty percent of its shares, making them the largest shareholder and the absolute controlling shareholder. The second and third shareholders were public funds, with Zhengjin Company and Huigin Company each holding five percent of the shares. The equity of the other shareholders was considerably diluted, posing no threat to the control of the Ouyang Family.
